Vaccination can also lower your chances of other serious shingles complications. For example, if it shows up on your face, ...

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...

Q3 2024 Earnings Call Transcript November 7, 2024Dynavax Technologies Corporation beats earnings expectations.

Detailed price information for Dynavax Technologies (DVAX-Q) from The Globe and Mail including charting and trades.

New study reveals potential cognitive benefits of Shingrix vaccine. The shingles shot may offer protection against dementia, especially in women.

Q: What inspired you to pursue a master's in public health (MPH) at UD? Free: As a pre-medical student in undergrad, I initially focused on the clinical side of healthcare. However, after taking a ...

Based on the shingles incidence rate from the placebo arm North American cohort of ZOSTER-006, a Phase 3 trial of Shingrix, 10 of the 876 participants in the Phase 2 trial should have been diagnosed ...

GSK's vaccine sales, including RSV and Shingrix, decline amid changing US recommendations, impacting Q3 performance and ...

To pile on, GSK’s flagship shingles vaccine Shingrix also saw a 10% sales reduction in the third quarter to 739 million pounds ($956 million). The number missed analysts’ projections by 13%.